Gainers

• Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-market session. The company's market cap stands at $33.0 million.
• INVO Fertility (NASDAQ:IVF) shares moved upwards by 46.77% to $1.82. The company's market cap stands at $2.2 million. As per the press release, Q1 earnings came out 4 days ago.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 23.28% to $4.66. The market value of their outstanding shares is at $2.2 million.
• Can Fite Biopharma (AMEX:CANF) stock rose 15.98% to $3.41. The company's market cap stands at $6.2 million.
• ACADIA Pharmaceuticals (NASDAQ:ACAD) stock increased by 14.45% to $27.15. The market value of their outstanding shares is at $4.0 billion.
• SANUWAVE Health (NASDAQ:SNWV) stock rose 13.76% to $8.68. The company's market cap stands at $65.6 million.

Losers

• Creative Medical Tech (NASDAQ:CELZ) stock declined by 28.0% to $1.44 during Friday's pre-market session. The market value of their outstanding shares is at $7.3 million.
• Omeros (NASDAQ:OMER) shares fell 18.85% to $8.7. The market value of their outstanding shares is at $775.8 million.
• NewGenIvf Group (NASDAQ:NIVF) stock decreased by 16.6% to $0.5. The market value of their outstanding shares is at $6.0 million.
• Nano X Imaging (NASDAQ:NNOX) shares declined by 13.58% to $0.76. The company's market cap stands at $51.4 million. As per the news, the Q1 earnings report came out yesterday.
• Catheter Precision (AMEX:VTAK) stock declined by 12.86% to $1.05. The company's market cap stands at $3.2 million.
• Pulsenmore (NASDAQ:PLSM) stock fell 10.63% to $5.27. The market value of their outstanding shares is at $38.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.